Mono Pharmacare Ltd (MONOPHARMA) is currently trading at N/A per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Mono Pharmacare Limited is engaged in the marketing and distribution of pharmaceutical products, operating since 1994. Their portfolio includes antibiotics, antifungals, skincare, and cardiac drugs, manufactured through contract partners. The company transitioned from a partnership to a public limited entity in October 2022, indicating an organized structural evolution for better market access and capital acquisition. In August 2023, Mono Pharmacare launched an IPO raising Rs 14.84 crore, suggesting strategic financial planning to fuel future growth and opportunities. The company has actively acquired related entities, consolidating operational strengths and expanding market coverage in the industry. Mono Pharmacare is led by Promoters Panilam and Supal Lakhatariya, who have been strategically acquiring related firms to bolster the company's value proposition.

Over the past 52 weeks, Mono Pharmacare Ltd has traded between a low of ₹7.50 and a high of ₹24.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Mono Pharmacare Ltd has a market capitalization of approximately 14.49. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Mono Pharmacare Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 41.40 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 14.49 Cr, Mono Pharmacare Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Mono Pharmacare Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Mono Pharmacare Ltd is 41.40. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.